Abdulraheem Yacoub

11PUBLICATIONS
100CO-AUTHORS
Gene and molecular therapyHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Liquid biopsiesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 29, 2026
The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 study.

|Jan 28, 2026
Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study.

Jason Gotlib, Andreas Reiter, Deepti H Radia

|Jul 13, 2023
A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis.

John Mascarenhas, Anna Rita Migliaccio, Heidi Kosiorek

|Oct 25, 2022
Use of endpoints in phase III randomized controlled trials for acute myeloid leukemia over the last 15 years: a systematic review.

Moazzam Shahzad, Sibgha Gull Chaudhary, Ezza Tariq

|Oct 18, 2022
Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical Trial.

Jesus D Gonzalez-Lugo, Suman Kambhampati, Abdulraheem Yacoub

|Jun 28, 2022
Targeting the PI3K pathway in myeloproliferative neoplasms.

Aaron T Gerds, Niccolo Bartalucci, Albert Assad

Pageof 2

Frequent Collaborators

5 joint publications

Alessandro Maria Vannucchi

4 joint publications

Aaron T Gerds

3 joint publications

John Mascarenhas

3 joint publications

Ruben Mesa